Market Research Logo

Global Microbiome Sequencing Services Market Analysis 2017 - Forecast to 2025

Global Microbiome Sequencing Services Market Analysis 2017 - Forecast to 2025

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2014 to 2023 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Human Microbiome Research Services Market by Therapeutics
5.1 Introduction
5.2 Drug and Biomarker Discovery
5.3 Genetic Screening
5.4 Idiopathic Diseases
5.5 Infectious Diseases
5.6 Oncology
5.7 Personalized Medicine
5.8 Others
6 Human Microbiome Research Services Market by Application
6.1 Introduction
6.2 Whole Genome Sequencing
6.3 Targeted Gene Sequencing
6.4 Shotgun Sequencing
6.5 Rna Sequencing
6.6 Other Applications
7 Human Microbiome Research Services Market by Technology
7.1 Introduction
7.2 Sanger Sequencing
7.3 Sequencing By Synthesis (SBS)
7.4 Pyrosequencing
7.5 Sequencing By Ligation (SBL)
7.6 Other Technologies
8 Human Microbiome Research Services Market by Research Type
8.1 Introduction
8.2 Internal
8.3 Outsourced
9 Human Microbiome Research Services Market by End User
9.1 Introduction
9.2 Academia/Research Institutes
9.3 Pharmaceutical and Biotechnology Companies
10 Human Microbiome Research Services Market by Laboratory Type
10.1 Introduction
10.2 Dry Labs
10.3 Wet Labs
11 Geographical Segmentation
11.1 North America
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 UK
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia Pacific
11.3.1 Japan
11.3.2 China
11.3.3 India
11.3.4 Australia
11.3.5 South Korea
11.3.6 Rest of Asia Pacific
11.4 South America
11.4.1 Argentina
11.4.2 Brazil
11.4.3 Venezuela
11.4.4 Chile
11.4.5 Peru
11.5 Middle East & Africa
11.5.1 UAE
11.5.2 Saudi Arabia
11.5.3 Qatar
11.5.4 Iran
11.5.5 South Africa
11.5.6 Rest of MEA
12 Vendor Landscaping
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiles
13.1 Metabiomics Corp.
13.1.1 Business Overview
13.1.2 SWOT Analysis
13.1.3 Financial Overview
13.1.4 Strategy
13.1.5 Key Activities
13.2 Rancho Biosciences
13.3 Diversigen, Inc.
13.4 Clinical-Microbiomics A/S
13.5 Ubiome, Inc.
13.6 Zymo Research Corp.
13.7 Openbiome
13.8 Shanghai Realbio Technology Co., Ltd
13.9 Molzym GmbH & Co. Kg
13.10 Baseclear B.V.
13.11 Microbiome Insights Inc.
13.12 Merieux Nutrisciences Corporation
13.13 Resphera Biosciences, LLC.
13.14 MR DNA (Molecular Research Lp)
13.15 Microbiome Therapeutics, LLC.
14 Appendix
15 Disclaimer
List of Tables
Table 1 Global Human Microbiome Research Services Analysis, by Region, (2014-2025) ($MN)
Table 2 Global Human Microbiome Research Services Analysis, by Therapeutics, (2014-2025) ($MN
Table 3 Global Human Microbiome Research Services Analysis, by Drug and Biomarker Discovery , (2014-2025) ($MN
Table 4 Global Human Microbiome Research Services Analysis, by Genetic Screening, (2014-2025) ($MN
Table 5 Global Human Microbiome Research Services Analysis, by Idiopathic Diseases, (2014-2025) ($MN
Table 6 Global Human Microbiome Research Services Analysis, by Infectious Diseases, (2014-2025) ($MN
Table 7 Global Human Microbiome Research Services Analysis, by Oncology, (2014-2025) ($MN
Table 8 Global Human Microbiome Research Services Analysis, by Personalized Medicine, (2014-2025) ($MN
Table 9 Global Human Microbiome Research Services Analysis, by Others, (2014-2025) ($MN
Table 10 Global Human Microbiome Research Services Analysis, by Application, (2014-2025) ($MN
Table 11 Global Human Microbiome Research Services Analysis, by Whole Genome Sequencing, (2014-2025) ($MN
Table 12 Global Human Microbiome Research Services Analysis, by Targeted Gene Sequencing, (2014-2025) ($MN
Table 13 Global Human Microbiome Research Services Analysis, by Shotgun Sequencing, (2014-2025) ($MN
Table 14 Global Human Microbiome Research Services Analysis, by Rna Sequencing, (2014-2025) ($MN
Table 15 Global Human Microbiome Research Services Analysis, by Other Applications, (2014-2025) ($MN
Table 16 Global Human Microbiome Research Services Analysis, by Technology, (2014-2025) ($MN
Table 17 Global Human Microbiome Research Services Analysis, by Sanger Sequencing, (2014-2025) ($MN
Table 18 Global Human Microbiome Research Services Analysis, by Sequencing By Synthesis (SBS), (2014-2025) ($MN
Table 19 Global Human Microbiome Research Services Analysis, by Pyrosequencing, (2014-2025) ($MN
Table 20 Global Human Microbiome Research Services Analysis, by Sequencing By Ligation (SBL), (2014-2025) ($MN
Table 21 Global Human Microbiome Research Services Analysis, by Other Technologies, (2014-2025) ($MN
Table 22 Global Human Microbiome Research Services Analysis, by Research Type, (2014-2025) ($MN
Table 23 Global Human Microbiome Research Services Analysis, by Internal, (2014-2025) ($MN
Table 24 Global Human Microbiome Research Services Analysis, by Outsourced, (2014-2025) ($MN
Table 25 Global Human Microbiome Research Services Analysis, by End User, (2014-2025) ($MN
Table 26 Global Human Microbiome Research Services Analysis, by Academia/Research Institutes, (2014-2025) ($MN
Table 27 Global Human Microbiome Research Services Analysis, by Pharmaceutical and Biotechnology Companies, (2014-2025) ($MN
Table 28 Global Human Microbiome Research Services Analysis, by Laboratory Type, (2014-2025) ($MN
Table 29 Global Human Microbiome Research Services Analysis, by Dry Labs, (2014-2025) ($MN
Table 30 Global Human Microbiome Research Services Analysis, by Wet Labs, (2014-2025) ($MN
Table 31 North America Human Microbiome Research Services Analysis, by Country, (2014-2025) ($MN)
Table 32 North America Human Microbiome Research Services Analysis, by Therapeutics, (2014-2025) ($MN
Table 33 North America Human Microbiome Research Services Analysis, by Drug and Biomarker Discovery , (2014-2025) ($MN
Table 34 North America Human Microbiome Research Services Analysis, by Genetic Screening, (2014-2025) ($MN
Table 35 North America Human Microbiome Research Services Analysis, by Idiopathic Diseases, (2014-2025) ($MN
Table 36 North America Human Microbiome Research Services Analysis, by Infectious Diseases, (2014-2025) ($MN
Table 37 North America Human Microbiome Research Services Analysis, by Oncology, (2014-2025) ($MN
Table 38 North America Human Microbiome Research Services Analysis, by Personalized Medicine, (2014-2025) ($MN
Table 39 North America Human Microbiome Research Services Analysis, by Others, (2014-2025) ($MN
Table 40 North America Human Microbiome Research Services Analysis, by Application, (2014-2025) ($MN
Table 41 North America Human Microbiome Research Services Analysis, by Whole Genome Sequencing, (2014-2025) ($MN
Table 42 North America Human Microbiome Research Services Analysis, by Targeted Gene Sequencing, (2014-2025) ($MN
Table 43 North America Human Microbiome Research Services Analysis, by Shotgun Sequencing, (2014-2025) ($MN
Table 44 North America Human Microbiome Research Services Analysis, by Rna Sequencing, (2014-2025) ($MN
Table 45 North America Human Microbiome Research Services Analysis, by Other Applications, (2014-2025) ($MN
Table 46 North America Human Microbiome Research Services Analysis, by Technology, (2014-2025) ($MN
Table 47 North America Human Microbiome Research Services Analysis, by Sanger Sequencing, (2014-2025) ($MN
Table 48 North America Human Microbiome Research Services Analysis, by Sequencing By Synthesis (SBS), (2014-2025) ($MN
Table 49 North America Human Microbiome Research Services Analysis, by Pyrosequencing, (2014-2025) ($MN
Table 50 North America Human Microbiome Research Services Analysis, by Sequencing By Ligation (SBL), (2014-2025) ($MN
Table 51 North America Human Microbiome Research Services Analysis, by Other Technologies, (2014-2025) ($MN
Table 52 North America Human Microbiome Research Services Analysis, by Research Type, (2014-2025) ($MN
Table 53 North America Human Microbiome Research Services Analysis, by Internal, (2014-2025) ($MN
Table 54 North America Human Microbiome Research Services Analysis, by Outsourced, (2014-2025) ($MN
Table 55 North America Human Microbiome Research Services Analysis, by End User, (2014-2025) ($MN
Table 56 North America Human Microbiome Research Services Analysis, by Academia/Research Institutes, (2014-2025) ($MN
Table 57 North America Human Microbiome Research Services Analysis, by Pharmaceutical and Biotechnology Companies, (2014-2025) ($MN
Table 58 North America Human Microbiome Research Services Analysis, by Laboratory Type, (2014-2025) ($MN
Table 59 North America Human Microbiome Research Services Analysis, by Dry Labs, (2014-2025) ($MN
Table 60 North America Human Microbiome Research Services Analysis, by Wet Labs, (2014-2025) ($MN
Table 61 Europe Human Microbiome Research Services Analysis, by Country, (2014-2025) ($MN)
Table 62 Europe Human Microbiome Research Services Analysis, by Therapeutics, (2014-2025) ($MN
Table 63 Europe Human Microbiome Research Services Analysis, by Drug and Biomarker Discovery , (2014-2025) ($MN
Table 64 Europe Human Microbiome Research Services Analysis, by Genetic Screening, (2014-2025) ($MN
Table 65 Europe Human Microbiome Research Services Analysis, by Idiopathic Diseases, (2014-2025) ($MN
Table 66 Europe Human Microbiome Research Services Analysis, by Infectious Diseases, (2014-2025) ($MN
Table 67 Europe Human Microbiome Research Services Analysis, by Oncology, (2014-2025) ($MN
Table 68 Europe Human Microbiome Research Services Analysis, by Personalized Medicine, (2014-2025) ($MN
Table 69 Europe Human Microbiome Research Services Analysis, by Others, (2014-2025) ($MN
Table 70 Europe Human Microbiome Research Services Analysis, by Application, (2014-2025) ($MN
Table 71 Europe Human Microbiome Research Services Analysis, by Whole Genome Sequencing, (2014-2025) ($MN
Table 72 Europe Human Microbiome Research Services Analysis, by Targeted Gene Sequencing, (2014-2025) ($MN
Table 73 Europe Human Microbiome Research Services Analysis, by Shotgun Sequencing, (2014-2025) ($MN
Table 74 Europe Human Microbiome Research Services Analysis, by Rna Sequencing, (2014-2025) ($MN
Table 75 Europe Human Microbiome Research Services Analysis, by Other Applications, (2014-2025) ($MN
Table 76 Europe Human Microbiome Research Services Analysis, by Technology, (2014-2025) ($MN
Table 77 Europe Human Microbiome Research Services Analysis, by Sanger Sequencing, (2014-2025) ($MN
Table 78 Europe Human Microbiome Research Services Analysis, by Sequencing By Synthesis (SBS), (2014-2025) ($MN
Table 79 Europe Human Microbiome Research Services Analysis, by Pyrosequencing, (2014-2025) ($MN
Table 80 Europe Human Microbiome Research Services Analysis, by Sequencing By Ligation (SBL), (2014-2025) ($MN
Table 81 Europe Human Microbiome Research Services Analysis, by Other Technologies, (2014-2025) ($MN
Table 82 Europe Human Microbiome Research Services Analysis, by Research Type, (2014-2025) ($MN
Table 83 Europe Human Microbiome Research Services Analysis, by Internal, (2014-2025) ($MN
Table 84 Europe Human Microbiome Research Services Analysis, by Outsourced, (2014-2025) ($MN
Table 85 Europe Human Microbiome Research Services Analysis, by End User, (2014-2025) ($MN
Table 86 Europe Human Microbiome Research Services Analysis, by Academia/Research Institutes, (2014-2025) ($MN
Table 87 Europe Human Microbiome Research Services Analysis, by Pharmaceutical and Biotechnology Companies, (2014-2025) ($MN
Table 88 Europe Human Microbiome Research Services Analysis, by Laboratory Type, (2014-2025) ($MN
Table 89 Europe Human Microbiome Research Services Analysis, by Dry Labs, (2014-2025) ($MN
Table 90 Europe Human Microbiome Research Services Analysis, by Wet Labs, (2014-2025) ($MN
Table 91 Asia Pacific Human Microbiome Research Services Analysis, by Country, (2014-2025) ($MN)
Table 92 Asia Pacific Human Microbiome Research Services Analysis, by Therapeutics, (2014-2025) ($MN
Table 93 Asia Pacific Human Microbiome Research Services Analysis, by Drug and Biomarker Discovery , (2014-2025) ($MN
Table 94 Asia Pacific Human Microbiome Research Services Analysis, by Genetic Screening, (2014-2025) ($MN
Table 95 Asia Pacific Human Microbiome Research Services Analysis, by Idiopathic Diseases, (2014-2025) ($MN
Table 96 Asia Pacific Human Microbiome Research Services Analysis, by Infectious Diseases, (2014-2025) ($MN
Table 97 Asia Pacific Human Microbiome Research Services Analysis, by Oncology, (2014-2025) ($MN
Table 98 Asia Pacific Human Microbiome Research Services Analysis, by Personalized Medicine, (2014-2025) ($MN
Table 99 Asia Pacific Human Microbiome Research Services Analysis, by Others, (2014-2025) ($MN
Table 100 Asia Pacific Human Microbiome Research Services Analysis, by Application, (2014-2025) ($MN
Table 101 Asia Pacific Human Microbiome Research Services Analysis, by Whole Genome Sequencing, (2014-2025) ($MN
Table 102 Asia Pacific Human Microbiome Research Services Analysis, by Targeted Gene Sequencing, (2014-2025) ($MN
Table 103 Asia Pacific Human Microbiome Research Services Analysis, by Shotgun Sequencing, (2014-2025) ($MN
Table 104 Asia Pacific Human Microbiome Research Services Analysis, by Rna Sequencing, (2014-2025) ($MN
Table 105 Asia Pacific Human Microbiome Research Services Analysis, by Other Applications, (2014-2025) ($MN
Table 106 Asia Pacific Human Microbiome Research Services Analysis, by Technology, (2014-2025) ($MN
Table 107 Asia Pacific Human Microbiome Research Services Analysis, by Sanger Sequencing, (2014-2025) ($MN
Table 108 Asia Pacific Human Microbiome Research Services Analysis, by Sequencing By Synthesis (SBS), (2014-2025) ($MN
Table 109 Asia Pacific Human Microbiome Research Services Analysis, by Pyrosequencing, (2014-2025) ($MN
Table 110 Asia Pacific Human Microbiome Research Services Analysis, by Sequencing By Ligation (SBL), (2014-2025) ($MN
Table 111 Asia Pacific Human Microbiome Research Services Analysis, by Other Technologies, (2014-2025) ($MN
Table 112 Asia Pacific Human Microbiome Research Services Analysis, by Research Type, (2014-2025) ($MN
Table 113 Asia Pacific Human Microbiome Research Services Analysis, by Internal, (2014-2025) ($MN
Table 114 Asia Pacific Human Microbiome Research Services Analysis, by Outsourced, (2014-2025) ($MN
Table 115 Asia Pacific Human Microbiome Research Services Analysis, by End User, (2014-2025) ($MN
Table 116 Asia Pacific Human Microbiome Research Services Analysis, by Academia/Research Institutes, (2014-2025) ($MN
Table 117 Asia Pacific Human Microbiome Research Services Analysis, by Pharmaceutical and Biotechnology Companies, (2014-2025) ($MN
Table 118 Asia Pacific Human Microbiome Research Services Analysis, by Laboratory Type, (2014-2025) ($MN
Table 119 Asia Pacific Human Microbiome Research Services Analysis, by Dry Labs, (2014-2025) ($MN
Table 120 Asia Pacific Human Microbiome Research Services Analysis, by Wet Labs, (2014-2025) ($MN
Table 121 South America Human Microbiome Research Services Analysis, by Country, (2014-2025) ($MN)
Table 122 South America Human Microbiome Research Services Analysis, by Therapeutics, (2014-2025) ($MN
Table 123 South America Human Microbiome Research Services Analysis, by Drug and Biomarker Discovery , (2014-2025) ($MN
Table 124 South America Human Microbiome Research Services Analysis, by Genetic Screening, (2014-2025) ($MN
Table 125 South America Human Microbiome Research Services Analysis, by Idiopathic Diseases, (2014-2025) ($MN
Table 126 South America Human Microbiome Research Services Analysis, by Infectious Diseases, (2014-2025) ($MN
Table 127 South America Human Microbiome Research Services Analysis, by Oncology, (2014-2025) ($MN
Table 128 South America Human Microbiome Research Services Analysis, by Personalized Medicine, (2014-2025) ($MN
Table 129 South America Human Microbiome Research Services Analysis, by Others, (2014-2025) ($MN
Table 130 South America Human Microbiome Research Services Analysis, by Application, (2014-2025) ($MN
Table 131 South America Human Microbiome Research Services Analysis, by Whole Genome Sequencing, (2014-2025) ($MN
Table 132 South America Human Microbiome Research Services Analysis, by Targeted Gene Sequencing, (2014-2025) ($MN
Table 133 South America Human Microbiome Research Services Analysis, by Shotgun Sequencing, (2014-2025) ($MN
Table 134 South America Human Microbiome Research Services Analysis, by Rna Sequencing, (2014-2025) ($MN
Table 135 South America Human Microbiome Research Services Analysis, by Other Applications, (2014-2025) ($MN
Table 136 South America Human Microbiome Research Services Analysis, by Technology, (2014-2025) ($MN
Table 137 South America Human Microbiome Research Services Analysis, by Sanger Sequencing, (2014-2025) ($MN
Table 138 South America Human Microbiome Research Services Analysis, by Sequencing By Synthesis (SBS), (2014-2025) ($MN
Table 139 South America Human Microbiome Research Services Analysis, by Pyrosequencing, (2014-2025) ($MN
Table 140 South America Human Microbiome Research Services Analysis, by Sequencing By Ligation (SBL), (2014-2025) ($MN
Table 141 South America Human Microbiome Research Services Analysis, by Other Technologies, (2014-2025) ($MN
Table 142 South America Human Microbiome Research Services Analysis, by Research Type, (2014-2025) ($MN
Table 143 South America Human Microbiome Research Services Analysis, by Internal, (2014-2025) ($MN
Table 144 South America Human Microbiome Research Services Analysis, by Outsourced, (2014-2025) ($MN
Table 145 South America Human Microbiome Research Services Analysis, by End User, (2014-2025) ($MN
Table 146 South America Human Microbiome Research Services Analysis, by Academia/Research Institutes, (2014-2025) ($MN
Table 147 South America Human Microbiome Research Services Analysis, by Pharmaceutical and Biotechnology Companies, (2014-2025) ($MN
Table 148 South America Human Microbiome Research Services Analysis, by Laboratory Type, (2014-2025) ($MN
Table 149 South America Human Microbiome Research Services Analysis, by Dry Labs, (2014-2025) ($MN
Table 150 South America Human Microbiome Research Services Analysis, by Wet Labs, (2014-2025) ($MN
Table 151 Middle East & Africa Human Microbiome Research Services Analysis, by Country, (2014-2025) ($MN)
Table 152 Middle East & Africa Human Microbiome Research Services Analysis, by Therapeutics, (2014-2025) ($MN
Table 153 Middle East & Africa Human Microbiome Research Services Analysis, by Drug and Biomarker Discovery , (2014-2025) ($MN
Table 154 Middle East & Africa Human Microbiome Research Services Analysis, by Genetic Screening, (2014-2025) ($MN
Table 155 Middle East & Africa Human Microbiome Research Services Analysis, by Idiopathic Diseases, (2014-2025) ($MN
Table 156 Middle East & Africa Human Microbiome Research Services Analysis, by Infectious Diseases, (2014-2025) ($MN
Table 157 Middle East & Africa Human Microbiome Research Services Analysis, by Oncology, (2014-2025) ($MN
Table 158 Middle East & Africa Human Microbiome Research Services Analysis, by Personalized Medicine, (2014-2025) ($MN
Table 159 Middle East & Africa Human Microbiome Research Services Analysis, by Others, (2014-2025) ($MN
Table 160 Middle East & Africa Human Microbiome Research Services Analysis, by Application, (2014-2025) ($MN
Table 161 Middle East & Africa Human Microbiome Research Services Analysis, by Whole Genome Sequencing, (2014-2025) ($MN
Table 162 Middle East & Africa Human Microbiome Research Services Analysis, by Targeted Gene Sequencing, (2014-2025) ($MN
Table 163 Middle East & Africa Human Microbiome Research Services Analysis, by Shotgun Sequencing, (2014-2025) ($MN
Table 164 Middle East & Africa Human Microbiome Research Services Analysis, by Rna Sequencing, (2014-2025) ($MN
Table 165 Middle East & Africa Human Microbiome Research Services Analysis, by Other Applications, (2014-2025) ($MN
Table 166 Middle East & Africa Human Microbiome Research Services Analysis, by Technology, (2014-2025) ($MN
Table 167 Middle East & Africa Human Microbiome Research Services Analysis, by Sanger Sequencing, (2014-2025) ($MN
Table 168 Middle East & Africa Human Microbiome Research Services Analysis, by Sequencing By Synthesis (SBS), (2014-2025) ($MN
Table 169 Middle East & Africa Human Microbiome Research Services Analysis, by Pyrosequencing, (2014-2025) ($MN
Table 170 Middle East & Africa Human Microbiome Research Services Analysis, by Sequencing By Ligation (SBL), (2014-2025) ($MN
Table 171 Middle East & Africa Human Microbiome Research Services Analysis, by Other Technologies, (2014-2025) ($MN
Table 172 Middle East & Africa Human Microbiome Research Services Analysis, by Research Type, (2014-2025) ($MN
Table 173 Middle East & Africa Human Microbiome Research Services Analysis, by Internal, (2014-2025) ($MN
Table 174 Middle East & Africa Human Microbiome Research Services Analysis, by Outsourced, (2014-2025) ($MN
Table 175 Middle East & Africa Human Microbiome Research Services Analysis, by End User, (2014-2025) ($MN
Table 176 Middle East & Africa Human Microbiome Research Services Analysis, by Academia/Research Institutes, (2014-2025) ($MN
Table 177 Middle East & Africa Human Microbiome Research Services Analysis, by Pharmaceutical and Biotechnology Companies, (2014-2025) ($MN
Table 178 Middle East & Africa Human Microbiome Research Services Analysis, by Laboratory Type, (2014-2025) ($MN
Table 179 Middle East & Africa Human Microbiome Research Services Analysis, by Dry Labs, (2014-2025) ($MN
Table 180 Middle East & Africa Human Microbiome Research Services Analysis, by Wet Labs, (2014-2025) ($MN

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report